These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 8961354

  • 1. Engineering the C-region of human insulin-like growth factor-1: implications for receptor binding.
    Gill R, Wallach B, Verma C, Ursø B, De Wolf E, Grötzinger J, Murray-Rust J, Pitts J, Wollmer A, De Meyts P, Wood S.
    Protein Eng; 1996 Nov; 9(11):1011-9. PubMed ID: 8961354
    [Abstract] [Full Text] [Related]

  • 2. Structural changes in insulin-like growth factor (IGF) I mutant proteins affecting binding kinetic rates to IGF binding protein 1 and IGF-I receptor.
    Jansson M, Uhlen M, Nilsson B.
    Biochemistry; 1997 Apr 08; 36(14):4108-17. PubMed ID: 9100004
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Positively charged side chains in the insulin-like growth factor-1 C- and D-regions determine receptor binding specificity.
    Zhang W, Gustafson TA, Rutter WJ, Johnson JD.
    J Biol Chem; 1994 Apr 08; 269(14):10609-13. PubMed ID: 8144650
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Refolding of amphioxus insulin-like peptide: implications of a bifurcating evolution of the different folding behavior of insulin and insulin-like growth factor 1.
    Wang S, Guo ZY, Shen L, Zhang YJ, Feng YM.
    Biochemistry; 2003 Aug 19; 42(32):9687-93. PubMed ID: 12911310
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The different energetic state of the intra A-chain/domain disulfide of insulin and insulin-like growth factor 1 is mainly controlled by their B-chain/domain.
    Guo ZY, Shen L, Feng YM.
    Biochemistry; 2002 Aug 27; 41(34):10585-92. PubMed ID: 12186542
    [Abstract] [Full Text] [Related]

  • 16. [The structural organization of binding determinants in insulin-like growth factor-I (IGF-I) molecule].
    Kolychev AP.
    Zh Evol Biokhim Fiziol; 2010 Aug 27; 46(1):74-94. PubMed ID: 20297673
    [Abstract] [Full Text] [Related]

  • 17. Sequences of B-chain/domain 1-10/1-9 of insulin and insulin-like growth factor 1 determine their different folding behavior.
    Chen Y, You Y, Jin R, Guo ZY, Feng YM.
    Biochemistry; 2004 Jul 20; 43(28):9225-33. PubMed ID: 15248780
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.